Selected research
Market Structure
Global Gadopentetate Dimeglumine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gadopentetate Dimeglumine API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gadopentetate Dimeglumine API include Shanghai New Hualian Pharmaceutical, Seven Star Pharmaceutical, Guangdong Xianqiang Pharmaceutical, Beijing Beilu Pharmaceutical and Biophore, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gadopentetate Dimeglumine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gadopentetate Dimeglumine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gadopentetate Dimeglumine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadopentetate Dimeglumine API market size, projected growth trends, production technologies, key applications, and end-use industries.
Gadopentetate Dimeglumine API Segment by Company
Shanghai New Hualian Pharmaceutical
Seven Star Pharmaceutical
Guangdong Xianqiang Pharmaceutical
Beijing Beilu Pharmaceutical
Biophore
Gadopentetate Dimeglumine API Segment by Type
Purity ≥98%
Purity ≥99%
Gadopentetate Dimeglumine API Segment by Application
CNS Contrast Agent
Liver Contrast Agent
Others
Gadopentetate Dimeglumine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadopentetate Dimeglumine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gadopentetate Dimeglumine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadopentetate Dimeglumine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gadopentetate Dimeglumine API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gadopentetate Dimeglumine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gadopentetate Dimeglumine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Gadopentetate Dimeglumine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥98%
- Purity ≥99%
Applications
- CNS Contrast Agent
- Liver Contrast Agent
- Others
Companies covered
- Shanghai New Hualian Pharmaceutical
- Seven Star Pharmaceutical
- Guangdong Xianqiang Pharmaceutical
- Beijing Beilu Pharmaceutical
- Biophore
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gadopentetate Dimeglumine API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gadopentetate Dimeglumine API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Gadopentetate Dimeglumine API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Gadopentetate Dimeglumine API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Gadopentetate Dimeglumine API Market Dynamics
- 2.1 Gadopentetate Dimeglumine API Industry Trends
- 2.2 Gadopentetate Dimeglumine API Industry Drivers
- 2.3 Gadopentetate Dimeglumine API Industry Opportunities and Challenges
- 2.4 Gadopentetate Dimeglumine API Industry Restraints
3 Gadopentetate Dimeglumine API Market by Manufacturers
- 3.1 Global Gadopentetate Dimeglumine API Revenue by Manufacturers (2021-2026)
- 3.2 Global Gadopentetate Dimeglumine API Sales by Manufacturers (2021-2026)
- 3.3 Global Gadopentetate Dimeglumine API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Gadopentetate Dimeglumine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gadopentetate Dimeglumine API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Gadopentetate Dimeglumine API Manufacturers, Product Type & Application
- 3.7 Global Gadopentetate Dimeglumine API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gadopentetate Dimeglumine API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gadopentetate Dimeglumine API Players Market Share by Revenue in 2025
- 3.8.3 2025 Gadopentetate Dimeglumine API Tier 1, Tier 2, and Tier 3
4 Gadopentetate Dimeglumine API Market by Type
- 4.1 Gadopentetate Dimeglumine API Type Introduction
- 4.1.1 Purity ≥98%
- 4.1.2 Purity ≥99%
- 4.2 Global Gadopentetate Dimeglumine API Sales by Type
- 4.2.1 Global Gadopentetate Dimeglumine API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gadopentetate Dimeglumine API Sales by Type (2021-2032)
- 4.2.3 Global Gadopentetate Dimeglumine API Sales Market Share by Type (2021-2032)
- 4.3 Global Gadopentetate Dimeglumine API Revenue by Type
- 4.3.1 Global Gadopentetate Dimeglumine API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gadopentetate Dimeglumine API Revenue by Type (2021-2032)
- 4.3.3 Global Gadopentetate Dimeglumine API Revenue Market Share by Type (2021-2032)
5 Gadopentetate Dimeglumine API Market by Application
- 5.1 Gadopentetate Dimeglumine API Application Introduction
- 5.1.1 CNS Contrast Agent
- 5.1.2 Liver Contrast Agent
- 5.1.3 Others
- 5.2 Global Gadopentetate Dimeglumine API Sales by Application
- 5.2.1 Global Gadopentetate Dimeglumine API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gadopentetate Dimeglumine API Sales by Application (2021-2032)
- 5.2.3 Global Gadopentetate Dimeglumine API Sales Market Share by Application (2021-2032)
- 5.3 Global Gadopentetate Dimeglumine API Revenue by Application
- 5.3.1 Global Gadopentetate Dimeglumine API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gadopentetate Dimeglumine API Revenue by Application (2021-2032)
- 5.3.3 Global Gadopentetate Dimeglumine API Revenue Market Share by Application (2021-2032)
6 Global Gadopentetate Dimeglumine API Sales by Region
- 6.1 Global Gadopentetate Dimeglumine API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gadopentetate Dimeglumine API Sales by Region (2021-2032)
- 6.2.1 Global Gadopentetate Dimeglumine API Sales by Region (2021-2026)
- 6.2.2 Global Gadopentetate Dimeglumine API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gadopentetate Dimeglumine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gadopentetate Dimeglumine API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gadopentetate Dimeglumine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gadopentetate Dimeglumine API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gadopentetate Dimeglumine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gadopentetate Dimeglumine API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Gadopentetate Dimeglumine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Gadopentetate Dimeglumine API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Gadopentetate Dimeglumine API Revenue by Region
- 7.1 Global Gadopentetate Dimeglumine API Revenue by Region
- 7.1.1 Global Gadopentetate Dimeglumine API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Gadopentetate Dimeglumine API Revenue by Region (2021-2026)
- 7.1.3 Global Gadopentetate Dimeglumine API Revenue by Region (2027-2032)
- 7.1.4 Global Gadopentetate Dimeglumine API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Gadopentetate Dimeglumine API Revenue (2021-2032)
- 7.2.2 North America Gadopentetate Dimeglumine API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Gadopentetate Dimeglumine API Revenue (2021-2032)
- 7.3.2 Europe Gadopentetate Dimeglumine API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Gadopentetate Dimeglumine API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Gadopentetate Dimeglumine API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Gadopentetate Dimeglumine API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Gadopentetate Dimeglumine API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shanghai New Hualian Pharmaceutical
- 8.1.1 Shanghai New Hualian Pharmaceutical Company Information
- 8.1.2 Shanghai New Hualian Pharmaceutical Business Overview
- 8.1.3 Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
- 8.1.5 Shanghai New Hualian Pharmaceutical Recent Developments
- 8.2 Seven Star Pharmaceutical
- 8.2.1 Seven Star Pharmaceutical Company Information
- 8.2.2 Seven Star Pharmaceutical Business Overview
- 8.2.3 Seven Star Pharmaceutical Gadopentetate Dimeglumine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Seven Star Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
- 8.2.5 Seven Star Pharmaceutical Recent Developments
- 8.3 Guangdong Xianqiang Pharmaceutical
- 8.3.1 Guangdong Xianqiang Pharmaceutical Company Information
- 8.3.2 Guangdong Xianqiang Pharmaceutical Business Overview
- 8.3.3 Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
- 8.3.5 Guangdong Xianqiang Pharmaceutical Recent Developments
- 8.4 Beijing Beilu Pharmaceutical
- 8.4.1 Beijing Beilu Pharmaceutical Company Information
- 8.4.2 Beijing Beilu Pharmaceutical Business Overview
- 8.4.3 Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
- 8.4.5 Beijing Beilu Pharmaceutical Recent Developments
- 8.5 Biophore
- 8.5.1 Biophore Company Information
- 8.5.2 Biophore Business Overview
- 8.5.3 Biophore Gadopentetate Dimeglumine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Biophore Gadopentetate Dimeglumine API Product Portfolio
- 8.5.5 Biophore Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gadopentetate Dimeglumine API Value Chain Analysis
- 9.1.1 Gadopentetate Dimeglumine API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gadopentetate Dimeglumine API Production Mode & Process
- 9.2 Gadopentetate Dimeglumine API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gadopentetate Dimeglumine API Distributors
- 9.2.3 Gadopentetate Dimeglumine API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst